Perspectives on chronic cough in Korea

Abstract

Cough is a physiological reflex to protect the lower airways against aspiration and irritation, but it is also one of the most common medical problems in many parts of the world (1). In a study in Asian-Pacific countries, cough was the main reason for medical visits among patients with upper and lower respiratory diseases (2). In particular, chronic cough, usually defined as lasting eight or more weeks, has received much national and international attention, as it frequently persists for years, has significant physical, social, and psychological consequences, and is often refractory to treatments (3-11).Chronic cough is a globally prevalent condition, but its epidemiological and clinical considerations may be locally different (12)(13)(14). In Korea, since the first cough clinic was established in the 1990s, chronic cough has been one of the major research interests of allergy and respiratory specialists (9,15). Upper and lower airway diseases, such as rhinitis, sinusitis, asthma, or eosinophilic bronchitis, were found to be frequent in Korean adults with chronic cough (16,17), which formed the basis in setting priorities and formulating Review Article on the 3rd International Cough Conference

Cough presentation and cough-related healthcare utilization in tertiary care: analysis of routinely collected academic institutional database

“…Anterior nasal symptoms (rhinorrhea, sneezing, or nasal obstruction) were present in 51.8% of the patients, supporting previous observations that rhinitis or rhinosinusitis is the most common comorbidity in Korean patients with chronic cough [16][17][18]. Lower airway symptoms, T2 in ammation markers, and air ow obstruction were frequently positive in patients with chronic cough (Fig.…”

Differences between Staphylococcus aureus nasal carriage and IgE-sensitization to Staphylococcus aureus enterotoxin on risk factors and effects in adult population

“…In this study, 7.2% of participants were classified as having a cough for more than three weeks, which included subacute cough and chronic cough. This was a higher percentage than was previously reported for chronic cough in a Korean study (2.6–4.6%) [ 29 ].…”

Inhaled Corticosteroids for Chronic Cough: Yes or FeNO?

“…The recently published British Thoracic Society Clinical Statement on Chronic Cough in Adults [6] proposed that patients with a FeNO level > 25 ppb should be considered for a 4-week trial of ICS. This suggested cutpoint was based on a meta-analysis and is somewhat lower than values proposed by others as being predictive of an ICS response [8]. Clearly more evidence is required.…”